Toggle light / dark theme

Elevated low‐density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction

Posted in biotech/medical

Background The incidence of atherosclerotic cardiovascular disease increases with levels of low-density lipoprotein cholesterol (LDL-C). Yet, a paradox may exist where lower LDL-C levels at myocardial infarction (MI) are associated with poorer prognoses.